Formula Growth’s Trueblue TBI Stock Holding History

Formula Growth’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-96,884	Closed	-$1.83M	–	167
2016 Q2	$1.83M	Sell	96,884 -232,416	-71%	-$4.85M	0.45%	75
2016 Q1	$8.61M	Buy	+329,300	New	+$7.62M	2.06%	6

Other funds holding TBI

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Formula Growth's TBI Position: Q3 2016 in Review

Formula Growth sold out of Trueblue (TBI) in Q3 2016, closing a stake of 96,884 shares — an estimated $1.83M sold.

Formula Growth first reported a position in TBI in Q1 2016 and held it in 2 quarters. The position peaked at $8.61M in Q1 2016. 170 funds tracked by Wall St. Rank hold TBI as of Q3 2016.

Formula Growth reported no remaining Trueblue position as of Q3 2016 after selling out during the quarter.
Formula Growth sold 96,884 Trueblue shares in Q3 2016, an estimated $1.83M.
Formula Growth first reported a position in Trueblue in Q1 2016 and held it in 2 quarters.
Formula Growth's Trueblue position peaked at $8.61M in Q1 2016.
170 funds tracked by Wall St. Rank held Trueblue as of Q3 2016.

Based on Formula Growth's 13F filing for Q3 2016, filed 14 Nov 2016.